Literature DB >> 2017231

Erythropoietin.

A J Erslev1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2017231     DOI： 10.1056/NEJM199105093241907

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  55 in total

1.  The future of doping control in athletes. Issues related to blood sampling.

Authors:  K I Birkeland; P Hemmersbach
Journal:  Sports Med       Date:  1999-07       Impact factor: 11.136

2.  Clinical use of erythropoietin.

Authors:  J Powell
Journal:  West J Med       Date:  1992-01

Review 3.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

4.  Alternative procedures for reducing allogeneic blood transfusion in elective orthopedic surgery.

Authors:  Kathrin Kleinert; Oliver M Theusinger; Johannes Nuernberg; Clément M L Werner
Journal:  HSS J       Date:  2010-01-28

Review 5.  Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.

Authors:  R Whittington; L B Barradell; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

6.  Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients.

Authors:  M Majdan; A Ksiazek; A Bednarek-Skublewska; D Spasiewicz
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 7.  Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors.

Authors:  G S Chatta; D C Dale
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

8.  High-dose chemotherapy with autologous stem cell rescue in breast cancer.

Authors:  R O Dillman; N M Barth; S K Nayak; C DeLeon; A O'Connor; L Morrelli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 9.  Erythropoietin: a review.

Authors:  D M Ridley; F Dawkins; E Perlin
Journal:  J Natl Med Assoc       Date:  1994-02       Impact factor: 1.798

Review 10.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.